These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27699502)

  • 1. Haematopoietic stem cell transplantation survivorship and quality of life: is it a small world after all?
    Brice L; Gilroy N; Dyer G; Kabir M; Greenwood M; Larsen S; Moore J; Kwan J; Hertzberg M; Brown L; Hogg M; Huang G; Tan J; Ward C; Gottlieb D; Kerridge I
    Support Care Cancer; 2017 Feb; 25(2):421-427. PubMed ID: 27699502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late complications and quality of life assessment for survivors receiving allogeneic hematopoietic stem cell transplantation.
    Cheon J; Lee YJ; Jo JC; Kweon K; Koh S; Min YJ; Park SH; Lee SH; Kim HJ; Choi Y
    Support Care Cancer; 2021 Feb; 29(2):975-986. PubMed ID: 32556712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in Arab Muslim cancer survivors following hematopoietic stem cell transplantation: comparison with matched healthy group.
    Alaloul F; Brockopp DY; Andrykowski MA; Hall LA; Al Nusairat TS
    Support Care Cancer; 2015 Jul; 23(7):2157-64. PubMed ID: 25556704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of post traumatic growth in allogeneic hematopoietic stem cell transplantation survivors: a cross-sectional survey.
    McErlean G; Tapp C; Brice L; Gilroy N; Kabir M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Ward C; Kerridge I
    BMC Psychol; 2023 Aug; 11(1):235. PubMed ID: 37587508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Everyday life following hematopoietic stem cell transplantation: decline in physical symptoms within the first month and change-related predictors.
    Kroemeke A; Sobczyk-Kruszelnicka M; Kwissa-Gajewska Z
    Qual Life Res; 2018 Jan; 27(1):125-135. PubMed ID: 28900828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health status, late effects and long-term survivorship of allogeneic bone marrow transplantation: a retrospective study.
    Gifford G; Sim J; Horne A; Ma D
    Intern Med J; 2014 Feb; 44(2):139-47. PubMed ID: 24320824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Employment Status as an Indicator of Recovery and Function One Year after Hematopoietic Stem Cell Transplantation.
    Morrison EJ; Ehlers SL; Bronars CA; Patten CA; Brockman TA; Cerhan JR; Hogan WJ; Hashmi SK; Gastineau DA
    Biol Blood Marrow Transplant; 2016 Sep; 22(9):1690-1695. PubMed ID: 27220264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of the relationship between sense of coherence, depression, anxiety, and quality of life of haematopoietic stem cell transplant patients over time.
    Pillay B; Lee SJ; Katona L; De Bono S; Burney S; Avery S
    Psychooncology; 2015 Feb; 24(2):220-7. PubMed ID: 25052297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation.
    Andrykowski MA; Bishop MM; Hahn EA; Cella DF; Beaumont JL; Brady MJ; Horowitz MM; Sobocinski KA; Rizzo JD; Wingard JR
    J Clin Oncol; 2005 Jan; 23(3):599-608. PubMed ID: 15659507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late Complications and Quality of Life after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation.
    Clavert A; Peric Z; Brissot E; Malard F; Guillaume T; Delaunay J; Dubruille V; Le Gouill S; Mahe B; Gastinne T; Blin N; Harousseau JL; Moreau P; Milpied N; Mohty M; Chevallier P
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):140-146. PubMed ID: 27751934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-Related Quality of Life in leukemia Survivors of Allogeneic Hematopoietic Stem Cell Transplantation Employing the Mexican Reduced-Intensity Conditioning.
    González-Ramírez MP; Miravete-Lagunes K; Gómez-de-León A; Ponce-de-León S; Tenorio-Rojo AP; Martagón-Herrera NA; Hernández-Reyes JA; García-Villasenor A; Burguette E; Vallejo-Villalobos MF; Ruiz-Delgado GJ; Gómez-Almaguer D; Ruiz-Argüelles GJ
    Rev Invest Clin; 2015; 67(2):109-16. PubMed ID: 25938844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of Monitoring Physical Function for Quality of Life Assessments in Hematopoietic Stem Cell Transplantation Patients: A Prospective Cohort Study.
    Kim I; Koh Y; Shin D; Hong J; DO HJ; Kwon SH; Seo KS
    In Vivo; 2020; 34(2):771-777. PubMed ID: 32111783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of outpatient non-myeloablative haematopoietic stem cell transplantation in quality of life vs. conventional therapy.
    Cantú-Rodríguez OG; Sánchez-Cárdenas M; Treviño-Montemayor OR; Gutiérrez-Aguirre CH; Tarín-Arzaga L; Jaime-Pérez JC; Gómez-Almaguer D
    Psychol Health Med; 2016; 21(1):10-9. PubMed ID: 26125120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perception of late effects among long-term survivors after haematopoietic stem cell transplantation: Descriptive analysis and validation of the Brief Illness Perception Questionnaire. A sub-study of the PROVIVO study.
    Valenta S; De Geest S; Fierz K; Beckmann S; Halter J; Schanz U; Nair G; Kirsch M
    Eur J Oncol Nurs; 2017 Apr; 27():17-27. PubMed ID: 28279392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-phase differences in health-related quality of life, psychological status, and physical function between human leucocyte antigen-haploidentical and other allogeneic haematopoietic stem cell transplantation recipients.
    Morishita S; Kaida K; Yamauchi S; Wakasugi T; Ikegame K; Kodama N; Ogawa H; Domen K
    Eur J Oncol Nurs; 2015 Oct; 19(5):443-50. PubMed ID: 25911269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
    Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
    Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors.
    Nair AP; Barnett MJ; Broady RC; Hogge DE; Song KW; Toze CL; Nantel SH; Power MM; Sutherland HJ; Nevill TJ; Abou Mourad Y; Narayanan S; Gerrie AS; Forrest DL
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1437-44. PubMed ID: 25865648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer survivor's perspectives on the major challenge in the transition to survivorship.
    Fitch MI; Nicoll I; Lockwood G
    Patient Educ Couns; 2020 Nov; 103(11):2361-2367. PubMed ID: 32376142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The experience of survival following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia.
    Gifford G; Gilroy N; Dyer G; Brice L; Kabir M; Greenwood M; Larsen S; Moore J; Gottlieb D; Hertzberg M; Kwan J; Huang G; Tan J; Brown L; Hogg M; Ward C; Kerridge I
    Bone Marrow Transplant; 2016 Oct; 51(10):1361-1368. PubMed ID: 27214081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexuality and quality of life of patients with hematologic malignancy and hematopoietic stem cell transplantation: a critical review.
    Tsatsou I; Mystakidou K; Panagou E; Adamakidou T; Kalemikerakis I; Vastardi M; Gkovina O
    J BUON; 2020; 25(4):1693-1706. PubMed ID: 33099903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.